Greener Biopharm with Super Insulation LN2 system
30 November 2024
Cryogenics is transforming the biopharma industry, offering advanced solutions that enhance process efficiency and product yield.
Our super insulation technology is pivotal in these processes, especially for temperature-sensitive, protein-based products where maintaining ultra-low temperatures is critical.
- In biopharma, liquid nitrogen (LN2) is a preferred medium due to its environmentally friendly properties—it’s non-contaminating, naturally inert, and leaves no harmful residues.
However, converting nitrogen gas to its liquid form requires a significant amount of energy, as nitrogen must reach a chilling -196°C (-321°F) of temperature.
- Minimizing the potential heat leak into liquid nitrogen storage and distribution systems, e.g. Vacuum Jacketed Piping System is essential to maximize economic efficiency.
That’s where CSM Cryogenic’s super insulation technology comes in. Designed to prevent heat ingress and keep LN2 at optimal temperatures, our solution helps you reduce energy waste and lower operating costs.
Ready to take your biopharma process to the next level sustainably? Reach out to us for more information.
Back